FridayOct 21, 2011 3:35 pm

Thwapr, Inc. (THWI) Rolls Out New Comprehensive Content Management Online Dashboard System Aimed at Mobile Video Marketers

Thwapr, which has established itself as a leading presence in mobile video through the clever leadership of the Company’s ex-Apple, Avid and MTV pioneers in the field, unveiled their new platform for allowing marketers to seamlessly deploy, track and quantify mobile video campaigns, the Content Management Online Dashboard (CMOD). CEO of THWI, Bruce Goldstein, described the CMOD as the ultimate tool for real-time scoping of the efficacy of deployed content and touted the massive ease-of-use characteristics of the platform. With the CMOD, marketers can now simply upload and farm out video content to their mobile fan base with ease, all…

Continue Reading

FridayOct 21, 2011 2:50 pm

Vuzix Corp. (VUZI) Acquires Nokia License to Develop See-Through Optics

On October 21, Vuzix Corp. announced that the company has entered into an agreement with Nokia to produce see-through waveguide optics components intended for use in near-eye display systems, which would then be used in head- and eyewear-mounted video displays. These displays would be based on see-through Exit Pupil Expanding technology, which is proprietary to Nokia. Originating with products intended for defense research, Vuzix holds over fifty patents and supplies video eyewear to defense, consumer, and entertainment markets. Vuzix creates technologies that are used in tactical wearable displays, thermal sighting systems, and augmented reality systems. The company has won various…

Continue Reading

FridayOct 21, 2011 2:44 pm

Magnum Hunter Resources Corp. (MHR) Issues Oil and Gas Update

Magnum Hunter Resources issued an operational update on the company’s oil and gas development in the Williston Basin, where the company is pursuing the Three Forks Sanish formation. Magnum Hunter Resources reported the production results of three recent wells drilled and completed into the Three Forks Sanish formation. The names and initial production rates for these wells are: • Ranchero 18-19-163-98 - 862 barrels of oil equivalent (BOE) per day • Impala 23-14-163-98 – 673 BOE per day • Geralyn Marie 34-163-99 – 565 BOE per day All three wells are located in Divide County, North Dakota. Magnum Hunter Resources…

Continue Reading

FridayOct 21, 2011 2:04 pm

Capital Market Expert John Di Girolamo Joins Golden Phoenix (GPXM) Board of Directors

Golden Phoenix Minerals, Inc. was pleased to announce earlier today that on October 20th, 2011, its Board of Directors appointed Mr. John Di Girolamo to its Board, effective immediately. "The appointment of John Di Girolamo to our Board of Directors provides the Company with significant capital market and senior exchange expertise," commented Tom Klein, CEO of Golden Phoenix. "John's 15 years of financial and mining experience can be utilized in assisting our Board as an Independent Director." Mr. Di Girolamo has accumulated more than a decade of professional experience. He has participated in capital raises in excess of $200 million…

Continue Reading

FridayOct 21, 2011 1:54 pm

Athersys Inc. (ATHX) Forms Alliance with National Multiple Sclerosis Society Subsidiary to Advance Candidate for MS Treatment

Biopharmaceutical company Athersys Inc. and Fast Forward LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, today announced an alliance to fund the development of Athersys' MultiStem® adult stem cell platform for the treatment of Multiple Sclerosis (MS), a chronic, unpredictable neurological disease affecting the central nervous system. The MultiStem platform includes the treatment of chronic progressive forms of the disease, and was designed with the goal of accelerating the clinical application of MultiStem for patients diagnosed with MS. "We are pleased to partner with Athersys to develop a new approach to treat MS with their proprietary platform, MultiStem,"…

Continue Reading

FridayOct 21, 2011 1:49 pm

New Drug from Sunshine Biopharma, Inc. (SBFM) to Play Critical Role in Fight against Cancer

It’s easy to forget that, in spite of periodic frustrations and disappointments, very real progress has been and continues to be made in the war against cancer. Decades of research have given us a much better understanding of how cancer operates at the cellular level. Developments in cancer prevention, screening, and therapy have saved millions of lives. Although there are still 1.5 million new cases of cancer diagnosed in the U.S. every year, the country now also has at least 11 million survivors of various types of cancer. But it’s important to remember that virtually all types of cancer are…

Continue Reading

FridayOct 21, 2011 1:19 pm

Beacon Equity Research: Q3 Revenue and Reverse Acquisition Drives Clean Diesel Technologies (CDTI)

Clean Diesel Technologies, Inc. surged 21.35% higher during this morning’s trading session and has traded as high as $3.65 on the back of Q3 preliminary results. CDTI is a cleantech emissions reduction company that has also recently entered into an equity purchase agreement with the investing firm Lincoln Park Capital Fund. CDTI refers to the Catalytic Solutions, Inc. acquisition as the “Merger” and accounts for the reverse acquisition. Accordingly, Clean Diesel’s (the legal acquirer’s) consolidated financial statements are now those of CSI (the accounting acquirer), with the assets and liabilities and revenues and expenses of legacy Clean Diesel being included…

Continue Reading

FridayOct 21, 2011 9:52 am

OncoSec Medical Inc. (ONCS) Submits Device Master File to FDA for Medical System that Treats Solid Tumor Cancers

OncoSec Medical Inc., an advanced-stage biomedical company focused on commercializing therapeutic oncology products, today announced that they have submitted to the US Food and Drug administration (FDA) the Device Master File (DMF) for their patented Onco Medical System (OMS). The OncoSec Medical System has been shown to be safe and effective for the treatment of solid tumor cancer cells in numerous clinical trials. The regulatory filling of the DMF, which includes technical manufacturing, clinical and non-clinical information, allows the FDA to review the complete OncoSec Medical system when any investigational clinical study application references its use. "This DMF submission brings…

Continue Reading

ThursdayOct 20, 2011 2:32 pm

Tranzyme Pharma (TZYM) Listed on Deloitte’s 2011 Technology Fast 500

Located in North Carolina, Tranzyme is a late-stage biopharmaceutical company focused on discovering, developing and commercializing novel, mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. Today, Tranzyme took a major step towards prominence with the announcement they have been ranked as the 54th fastest growing company in North American on Deloitte’s 2011 Technology Fast 500. Leading the way at Tranzyme Pharma is Vipin Garg whom serves as the company’s President and CEO. In reference to this honor, Garg was quoted as saying, "We are very pleased to be recognized by Deloitte as one of the fastest growing…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered